GlobeNewswire by notified

Calibre Scientific Acquires AmpliTech, a French Distributor of Reagents and Instruments Specializing in Molecular Pathology, Cytogenetics, and Molecular Genetics

Share

LOS ANGELES, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of AmpliTech, a distributor of reagents and instruments to research and diagnostic laboratories with headquarters in Compiègne, France. AmpliTech further enhances Calibre Scientific’s growing distribution platform in Europe.

Founded in 1996, AmpliTech specializes in molecular pathology, cytogenetics, and molecular genetics (prenatal, postnatal, and oncology). The Company has established exclusive partnerships with leading international manufacturers of high-end in vitro diagnostics and research use only products. AmpliTech’s customer base includes universities, hospitals, and large public and private labs in France, Belgium, Luxembourg, and Switzerland.

With this acquisition, Calibre Scientific adds another valuable brand to its European distribution division. “AmpliTech has a long history of providing premium products to its customer base in France and abroad,” said Mike Brownleader, Chief Revenue Officer of Calibre Scientific. “We see various opportunities to bolster AmpliTech’s dominance in its space: by adding key new supplier relationships we will enhance the scope of their product offering, making AmpliTech the one-stop shop for all its customers’ needs.”

“I am very excited about the future of AmpliTech as part of Calibre Scientific,” said Susane Darchis, President and Owner of AmpliTech. “Over the last few years, I’ve evaluated several strategic alternatives for the business, but Calibre Scientific has always been at the top of my list. Their professional approach to the sales process along with their stellar reputation and global scale convinced me that this was the best long-term home for my employees, suppliers, and customers.”

About Calibre Scientific

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial, and biopharmaceutical communities. Calibre Scientific owns a portfolio of twenty-four life science and diagnostic companies that have an unrivaled ability to address the unique challenges of their respective markets. Our global reach extends to over 100 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to expand its product offering and global footprint to laboratories across a wide array of verticals and geographies. 

For more information, visit www.calibrescientific.com, or contact Brice Geoffrion, Director of Business Development, at bgeoffrion@calibrescientific.com, or +1 (310) 651-8285.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction: Publication of 2023 Annual Report of Azerion Group N.V.25.4.2024 23:27:00 CEST | Press release

Amsterdam, 25 April 2024 – Azerion announces that it has today published its annual report and audited financial results for the full year 2023 for Azerion Group N.V.. The Annual Report can be found at https://www.azerion.com/reports/. Contact: Investor Relations ir@azerion.com Media press@azerion.com About Azerion Founded in 2014, Azerion (EURONEXT: AZRN) is one of Europe’s largest digital advertising and entertainment media platforms. Azerion brings global scaled audiences to advertisers in an easy and cost-effective way, delivered through our proprietary technology, in a safe, engaging, and high quality environment, utilizing our strategic portfolio of owned and operated content with entertainment and other digital publishing partners. Having its roots in Europe and with its headquarters in Amsterdam, Azerion has commercial teams based in over 24 cities around the world to closely support our clients and partners to find and execute creative ways to make a real impact through advert

Publication of 2023 Annual Report of Azerion Group N.V.25.4.2024 22:42:41 CEST | Press release

Amsterdam, 25 April 2024 – Azerion announces that it has today published its annual report and audited financial results for the full year 2023 for Azerion Group N.V.. The Annual Report can be found at https://www.azerion.com/reports/. Contact: Investor Relations ir@azerion.com Media press@azerion.com About Azerion Founded in 2014, Azerion (EURONEXT: AZRN) is one of Europe’s largest digital advertising and entertainment media platforms. Azerion brings global scaled audiences to advertisers in an easy and cost-effective way, delivered through our proprietary technology, in a safe, engaging, and high quality environment, utilizing our strategic portfolio of owned and operated content with entertainment and other digital publishing partners. Having its roots in Europe and with its headquarters in Amsterdam, Azerion has commercial teams based in over 24 cities around the world to closely support our clients and partners to find and execute creative ways to make a real impact through advert

Tenaris Announces 2024 First Quarter Results25.4.2024 22:30:25 CEST | Press release

The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Net cash / debt, Free Cash Flow and Operating working capital days. See exhibit I for more details on these alternative performance measures. LUXEMBOURG, April 25, 2024 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”) today announced its results for the quarter ended March 31, 2024 in comparison with its results for the quarter ended March 31, 2023. Summary of 2024 First Quarter Results (Comparison with fourth and first quarter of 2023) 1Q 20244Q 20231Q 2023Net sales ($ million)3,4423,4151%4,141(17%)Operating

Combined General Meeting of May 16, 202425.4.2024 22:30:00 CEST | Press release

Châtillon, France, April 25, 2024 Combined General Meeting of May 16, 2024 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the “Company”), will hold its Combined General Meeting (the “General Meeting”) on May 16, 2024, at 10:00 a.m. CET at the Company’s new headquarters located at IRO Building, 107 Avenue de la République, 92320 Châtillon, France. The preliminary notice (avis de réunion) containing the detailed agenda, draft resolutions as well as instructions to participate and vote for this General Meeting was published in the French “Bulletin des Annonces Légales Obligatoires (BALO)” dated April 8, 2024 (No. 2400716). The meeting notice (avis de convocation) will be published in the BALO and in t

Millicom (Tigo) Board of Directors Appoints Marcelo Benitez as CEO25.4.2024 22:30:00 CEST | Press release

Millicom (Tigo) Board of Directors Appoints Marcelo Benitez as CEO Luxembourg, April 25, 2024 – Millicom announced today that its Board of Directors has appointed Marcelo Benitez as CEO of Millicom, effective June 1, 2024. Benitez has had a distinguished career with Millicom, having joined the company in Paraguay nearly 30 years ago and risen through the Company’s ranks to his most recent role as CEO of TIGO Panama. Benitez's selection completes the final phase of a succession planning and selection process, which included a thorough evaluation of internal and external candidates to ensure that the company's next CEO possesses the vision, experience, talent and leadership qualities necessary to deliver on Millicom's strategic plans. "After an extensive evaluation, it is clear to our Board that Marcelo is the right person to lead Millicom into the future”, indicated Mauricio Ramos, Chair of the Board of Directors of the Company. Under Marcelo’s leadership, TIGO Panama completed the succ

HiddenA line styled icon from Orion Icon Library.Eye